Debio Recherche Pharmaceutique S.A., commonly known as Debiopharm, is a prominent biopharmaceutical company headquartered in Switzerland (CH). Founded in 1971, Debiopharm has established itself as a leader in the development of innovative therapies for oncology and infectious diseases, focusing on both drug development and the commercialisation of novel treatments. With a strong presence in Europe and North America, Debiopharm is renowned for its commitment to advancing healthcare through cutting-edge research and development. The company’s core products include targeted therapies and companion diagnostics, which are distinguished by their precision and efficacy. Debiopharm's notable achievements include successful partnerships and collaborations that have propelled its market position, making it a key player in the biopharmaceutical industry. Through its dedication to improving patient outcomes, Debiopharm continues to shape the future of medicine.
We don't have data for Debio Recherche Pharmaceutique S.A., but we can show you information about their parent organization instead.
View parent company